Skip to main content

Table 4 Lipid and apolipoprotein mean concentrations (± SD) in controls and CAD patients.

From: Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

 

Control (N = 50)

CAD (N = 50)

P

TC (mmol/L)

4.01 ± 0.46

4.62 ± 0.9

<0.001

TG (mmol/L)

0.78 ± 1.78

1.76 ± 0.77

<0.001

HDL-C (mmol/L)

1.07 ± 0.12

0.92 ± 0.26

<0.001

LDL-C (mmol/L)

2.57 ± 0.44

2.95 ± 0.86

<0.01

Apo AI (g/L)

1.33 ± 0.17

1.04 ± 0.13

<0.001

Apo B (g/L)

0.76 ± 0.18

1.00 ± 0.35

<0.001

Apo E (mg/L)

50.24 ± 7.63

43.24 ± 11.33

<0.001

Apo B/ApoAI

0.59 ± 0.16

0.96 ± 0.31

<0.001

Homocysteine (μmol/L)

12.93 ± 1.12

16.6 ± 4.58

<0.001

  1. P: Student t-test probability for comparisons among Control and CAD groups.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X